PharmaShots | Incisive News in 3 Shots

Subscribe Now

immunotherapy

CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003

CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003

October 27, 2020

Roche's Tecentriq (atezolizumab) Receives MHLW's Approval as the First Immunotherapy for Extensive-Stage Small Cell Lung Cancer in Japan

Roche's Tecentriq (atezolizumab) Receives MHLW's Approval as the First Immunotherapy for Extensive-Stage Small Cell Lung Cancer in...

August 23, 2019

Immunotherapy Keytruda Exceeds Opdivo in Q2 sales

Immunotherapy Keytruda Exceeds Opdivo in Q2 sales

July 27, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us